Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Non-Operating Income/Expense data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Non-Operating Income/Expense |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$10.32B |
|
$3.06B |
|
$4.53B |
|
$14.85B |
|
$1.82B |
|
-- |
|
$177.19M |
|
$2.00B |
|
$12.85B |
|
$12.62B |
|
$12.85B |
|
3.29B |
|
| Cash Flow Statement Financials | |
$1.75B |
|
$-268.93M |
|
$-2.08B |
|
$3.67B |
|
$3.10B |
|
$-569.64M |
|
-- |
|
$-2.04B |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|